David James Vaughan

David James Vaughan discloses dealings in Antibe Therapeutics Inc. to SEDI. Between 10 June 2013 and 2 June 2021, the trades on record add up to 16 filings.

In open-market terms, that means 2 purchases worth €24k on one side and 6 sales worth €167k on the other. The net balance comes to €143k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises.

The record was last updated on 6 June 2021 with a transaction (€53k) in Antibe Therapeutics Inc. The most recent open-market purchase was published on 25 September 2020, 2,224 days ago. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.